TRCT
ASMB icon

Tower Research Capital (TRC)’s Assembly Biosciences ASMB Stock Holding History

Tower Research Capital (TRC)’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.1K Sell
544
-63
-10% -$1.8K ﹤0.01% 3679
2025
Q4 		$20.6K Buy
+607
New +$19.6K ﹤0.01% 3077
2025
Q3 		– Sell
-250
Closed -$4.53K – 5215
2025
Q2 		$4.53K Sell
250
-111
-31% -$1.46K ﹤0.01% 4311
2025
Q1 		$3.45K Buy
361
+12
+3% +$157 ﹤0.01% 4409
2024
Q4 		$5.51K Sell
349
-239
-41% -$3.85K ﹤0.01% 4276
2024
Q3 		$8.9K Sell
588
-192
-25% -$2.92K ﹤0.01% 3922
2024
Q2 		$10.7K Sell
780
-77
-9% -$1.1K ﹤0.01% 4128
2024
Q1 		$11.4K Sell
857
-225
-21% -$2.62K ﹤0.01% 3574
2023
Q4 		$10.6K Buy
+1,082
New +$10.3K ﹤0.01% 4221
2023
Q2 		– Sell
-2,597
Closed -$26K – 6029
2023
Q1 		$26K Sell
2,597
-1,671
-39% -$28.2K ﹤0.01% 3139
2022
Q4 		$66K Buy
4,268
+2,839
+199% +$48.5K ﹤0.01% 2138
2022
Q3 		$28K Buy
1,429
+749
+110% +$18.1K ﹤0.01% 3646
2022
Q2 		$17K Sell
680
-413
-38% -$9.51K ﹤0.01% 3939
2022
Q1 		$27K Buy
1,093
+1,009
+1,201% +$21.7K ﹤0.01% 3243
2021
Q4 		$2K Sell
84
-1,820
-96% -$59.7K ﹤0.01% 5597
2021
Q3 		$79K Buy
1,904
+254
+15% +$10.6K ﹤0.01% 2593
2021
Q2 		$77K Buy
1,650
+1,391
+537% +$68.9K ﹤0.01% 2635
2021
Q1 		$14K Buy
259
+103
+66% +$6.83K ﹤0.01% 4142
2020
Q4 		$11K Sell
156
-1,522
-91% -$179K ﹤0.01% 4244
2020
Q3 		$331K Buy
1,678
+1,028
+158% +$259K ﹤0.01% 2092
2020
Q2 		$182K Buy
+650
New +$152K 0.01% 1870
2019
Q3 		– Sell
-362
Closed -$59K – 4067
2019
Q2 		$59K Buy
362
+358
+8,950% +$68K ﹤0.01% 1490
2019
Q1 		$1K Sell
4
-4
-50% -$1.01K ﹤0.01% 3523
2018
Q4 		$2K Sell
8
-13
-62% -$3.76K ﹤0.01% 3300
2018
Q3 		$9K Buy
+21
New +$9.84K ﹤0.01% 2811
2018
Q2 		– Sell
-2
Closed -$1K – 3616
2018
Q1 		$1K Sell
2
-154
-99% -$95.5K ﹤0.01% 3044
2017
Q4 		$85K Buy
156
+77
+97% +$34.9K 0.01% 967
2017
Q3 		$33K Sell
79
-1
-1% -$306 ﹤0.01% 2341
2017
Q2 		$20K Buy
+80
New +$22.5K ﹤0.01% 1206
2016
Q4 		– Sell
-568
Closed -$50K – 3805
2016
Q3 		$50K Buy
568
+470
+480% +$36.3K 0.01% 1141
2016
Q2 		$7K Buy
98
+95
+3,167% +$6.23K ﹤0.01% 3105
2016
Q1 		$0 Sell
3
-111
-97% -$7.42K ﹤0.01% 4082
2015
Q4 		$10K Buy
114
+1
+0.9% +$109 ﹤0.01% 2087
2015
Q3 		$13K Buy
113
+63
+126% +$11.1K ﹤0.01% 2080
2015
Q2 		$12K Buy
50
+47
+1,567% +$9.07K ﹤0.01% 2514
2015
Q1 		$0 Sell
3
-132
-98% -$17.9K ﹤0.01% 4384
2014
Q4 		$12K Buy
135
+101
+297% +$9.95K ﹤0.01% 1966
2014
Q3 		$3K Buy
+34
New +$3.02K ﹤0.01% 3578
2013
Q4 		– Sell
-25
Closed -$4K – 4438
2013
Q3 		$4K Buy
+25
New +$3.83K ﹤0.01% 3768

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Tower Research Capital (TRC)'s ASMB Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Assembly Biosciences (ASMB) stake by 10% in Q1 2026, selling an estimated $1.8K and leaving 544 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3679.

Tower Research Capital (TRC) first reported a position in ASMB in Q3 2013 and has held it in 39 quarters since. The position peaked at $331K in Q3 2020. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • Tower Research Capital (TRC) held 544 shares of Assembly Biosciences worth $15.1K as of Q1 2026.
  • Tower Research Capital (TRC) sold 63 Assembly Biosciences shares in Q1 2026, an estimated $1.8K.
  • Assembly Biosciences made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3679 holding.
  • Tower Research Capital (TRC) first reported a position in Assembly Biosciences in Q3 2013 and has held it in 39 quarters since.
  • Tower Research Capital (TRC)'s Assembly Biosciences position peaked at $331K in Q3 2020.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.